[1] Wong RL,Winslow CM.Cooper KD. The rnechaniams of action of cyclosporin A in the treaunc:nt of p,oriasis. Immunol Today,1993,14,69.
[2] Halliday CGM,Knight BA,Muller HK. Reduction in murine Langerhans cells ATPase staining following topical but not systemic treatment with steroid and non-steroid immunosuppressants. Br J Dermatol, J 986,114,83.
[3] Teunissen MBM,de Jager MH,Kapsenberg ML,et al. Inhibitory effect of cyclosporin A on antigen and alloantigen presenting capacity of human epidermal Langerhans cells.Br J Dermatol,1991,125:309.
[4] 郭在培.冈本拓之,今村贞夫.人及豚鼠和小鼠表皮郎格罕细胞组织化学染色理想条件的探讨.中华皮肤科杂尔,1993,26:176.
[5] Berman B,France DS,Martinelli GP,et al. IVlodulation of expression of epidermal Langerhans cell properties following in situ exposure to glucocorticosteroids.J Invest Dermatol,1983,80:168.
[6] Lynch DH,Gurish MF.Daynes RA. Relationship between epidermal Langerhans cell density ATPase activity and the induction of contact hypersensitivity. J Immuno1,1981,126:1892.
[7] Aldridge RD,Thomson AW,Rankin R,et al. Inhibition of contact sensitivity reactions to DNFB by topical cyclosporin application in the guinea-pig. Clin Exp Immunol、1985,59:23.
[8] Guo ZP,Okamuto H,Imamura S.The effect of 1.25(OH)2 vitamine D3 on Langerhans cells and coW act hypersensitivity in mice. Arch Dermatol Res,1992,284,368. |
